Wang, Yuan <br/><br/>
MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation.  [electronic resource] 

 -  Thoracic cancer  Apr 2016 
 - 279-87 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1759-7706 
<br/><br/><label>Standard No.: </label>10.1111/1759-7714.12325  doi